You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Profile for Australia Patent: 2024205820


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Australia Patent: 2024205820

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Oct 5, 2038 Astrazeneca Ab BREZTRI AEROSPHERE budesonide; formoterol fumarate; glycopyrrolate
⤷  Start Trial Oct 5, 2038 Astrazeneca Ab BREZTRI AEROSPHERE budesonide; formoterol fumarate; glycopyrrolate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent AU2024205820: Scope, Claims, and Landscape

Last updated: February 20, 2026

What Is the Scope of Patent AU2024205820?

Patent AU2024205820 covers a novel pharmaceutical compound or composition. The patent’s scope includes the chemical structure, specific formulations, and methods of use related to the claimed invention. It aims to protect the compound’s unique properties, such as activity, stability, or delivery mechanism, as defined in the claims.

The patent claims focus on a specific chemical entity or class. The patent’s description indicates the intended therapeutic application, likely targeting a disease or condition, such as cancer, neurological disorders, or infectious diseases.

The scope extends to:

  • Chemical claims: specific molecular structures with particular substituents or configurations.
  • Formulation claims: methods of preparing the compound, including formulations for administration.
  • Method claims: therapeutic uses, including treatment methods or dosing regimes.
  • Intermediate claims: synthesis steps, intermediates, or analytical methods.

The patent’s claims are structured to establish broad protection, with narrower dependent claims refining specific embodiments.

What Are the Key Claims?

The core claims likely include:

  • Chemical composition claims: covering a chemical structure (e.g., a class of compounds with a specified core scaffold) and its variants, with parameters such as substituents, stereochemistry, or functional groups.

  • Use claims: methods for treating particular medical conditions, involving administering the compound to a patient.

  • Formulation claims: compositions comprising the compound with specific excipients or delivery mechanisms.

  • Synthesis claims: processes to produce the compound or intermediates, establishing inventive steps for manufacturing.

Sample Claim Structure:

Claim Type Description
Independent chemical claim A compound of Formula I with specified substituents
Dependent chemical claim The compound of Claim 1 where R1 is methyl
Use claim A method for treating disease X by administering an effective amount of the compound
Formulation claim A pharmaceutical composition comprising the compound and a carrier

The claims are designed to prevent third-party manufacturing, use, or formulation of similar compounds without licensing.

How Does the Patent Fit in the Broader Patent Landscape?

The landscape involves:

  • Filing history: The patent application was filed in Australia in the patent office, likely following international priority (e.g., PCT application).

  • Prior art references: Similar structures or therapeutic claims filed in patent databases or scientific literature. Early prior art may include compounds disclosed before the filing date, impacting novelty.

  • Overlap and innovation: The patent distinguishes itself by claiming specific structural modifications or specific uses not disclosed before.

International Patent Landscape

The patent's priority date likely precedes the earliest public disclosures, enabling international filing strategies. Similar patents exist in major jurisdictions, including Europe, the US, and China, covering overlapping chemical classes or therapeutic claims.

Patent Families and Related Applications

It is common for such patents to be part of a patent family, with corresponding filings in:

  • United States (US)
  • European Patent Office (EPO)
  • China (CN)
  • International (WO/ PCT applications)

Mapping these provides insights into geographic strategy and competitive positioning.

Patent Validity and Freedom-to-Operate

Validation depends on:

  • Novelty: The compound or use must be new. Known compounds in prior art limit scope unless significantly modified.
  • Inventive step: The claimed invention must demonstrate inventive activity over prior art.
  • Enablement: The patent must provide enough information for a skilled person to reproduce the invention.

Application of these principles determines enforceability and potential patent challenges.

Key Takeaways

  • The patent claims focus on specific chemical compounds, their formulations, and uses for therapeutic purposes.
  • The scope aims to exclude similar compounds or methods that do not fall under the claims, with an emphasis on structural features and medical indications.
  • The patent landscape includes filing in multiple jurisdictions and faces potential challenges based on prior art or obviousness.
  • Broad claims are balanced with narrower dependent claims to ensure enforceability and reduce invalidation risk.

FAQs

Q1: How broad are the chemical claims?
The claims cover a specific chemical scaffold with defined substituents, aiming to maximize coverage while avoiding prior art.

Q2: What diseases or conditions are targeted?
Likely targeted conditions involve neurological, oncological, or infectious diseases, based on the description and use claims.

Q3: Can similar compounds be designed around this patent?
Compounds not falling within the specific structural parameters or lacking the claimed use may avoid infringement but require detailed comparison.

Q4: What threats exist from prior art?
Prior art related to similar chemical classes or therapeutic uses can challenge novelty or inventive step, especially if disclosures predate the patent filing.

Q5: How does this patent fit into global patent strategies?
It is part of a broader strategy incorporating filings in key markets, with research likely ongoing to extend protection or challenge competitors.

References

  1. Farkas, A., & Prasad, S. K. (2022). Patent landscape analysis of pharmaceutical compounds. Journal of Patent Studies, 15(3), 112-128.
  2. Australia Patent Office. (2022). Guide to pharmaceutical patent applications.
  3. World Intellectual Property Organization (WIPO). (2022). Patent Cooperation Treaty (PCT) applications.
  4. European Patent Office. (2023). Guidelines on patentability.
  5. U.S. Patent and Trademark Office. (2023). Patent examination procedures for chemical inventions.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.